Literature DB >> 25502918

APECED syndrome in childhood: clinical spectrum is enlarging.

Mariella Valenzise1, Luca Alessi, Enrico Bruno, Valeria Cama, Daria Costanzo, Cristina Genovese, Cristina Mignosa, Veronica Scuderi, Filippo DE Luca.   

Abstract

Autoimmune polyendocrinopathy-candidiasis-ectodermal-distrophy (APECED) is a rare autosomal recessive disease, which is mainly characterized by the association of many autoimmune diseases, with a classic triad including chronic mucocutaneous candidiasis, hypoparathyroidism and adrenocortical failure. Its clinical spectrum has significantly enlarged in the last years and other non-classic components have been recently described. Aim of this review was to alert pediatricians to these novel clinical aspects of this syndrome, that have been recently included among the autoimmune APECED manifestations: a) chronic lung disease, that may evolve to cor pulmonale and terminal respiratory failure; b) chronic inflammatory demyelinating polineuropathy, with progressive muscular weakness of both arms and legs and sensory loss; c) gastrointestinal dysfunction, with recurrent diarrhea, malabsorption and steatorrhea or chronic constipation. For each of these novel components of APECED, specific autoantibodies against either lung autoantigens or peripheral nerves or tryptophan hydroxylase have been just recently identified.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25502918

Source DB:  PubMed          Journal:  Minerva Pediatr        ISSN: 0026-4946            Impact factor:   1.312


  2 in total

1.  Novel insight into Chronic Inflammatory Demyelinating Polineuropathy in APECED syndrome: molecular mechanisms and clinical implications in children.

Authors:  Mariella Valenzise; Tommaso Aversa; Giuseppina Salzano; Giuseppina Zirilli; Filippo De Luca; Maureen Su
Journal:  Ital J Pediatr       Date:  2017-01-19       Impact factor: 2.638

2.  Epidemiological and clinical peculiarities of polyglandular syndrome type 3 in pediatric age.

Authors:  Mariella Valenzise; Tommaso Aversa; Angiola Saccomanno; Filippo De Luca; Giuseppina Salzano
Journal:  Ital J Pediatr       Date:  2017-08-07       Impact factor: 2.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.